The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

  • China to boost economic rebound, stabilize foreign trade, investment

  • Senior Australian ministers to visit France, Britain to boost ties

  • Does That Call For Deeper Study Of Its Financial Prospects?

Stock Shares
Home›Stock Shares›Ruba Borno Acquires 937 Shares of Experian plc (LON:EXPN) Stock

Ruba Borno Acquires 937 Shares of Experian plc (LON:EXPN) Stock

By Megan
June 30, 2022
51
0
Share:

Experian logoExperian plc (LON:EXPN – Get Rating) insider Ruba Borno bought 937 shares of Experian stock in a transaction on Thursday, June 30th. The stock was acquired at an average cost of GBX 2,385 ($29.26) per share, for a total transaction of £22,347.45 ($27,416.82).

LON:EXPN traded down GBX 18 ($0.22) on Thursday, reaching GBX 2,406 ($29.52). 1,517,064 shares of the stock traded hands, compared to its average volume of 1,680,731. The firm has a market capitalization of £22.15 billion and a price-to-earnings ratio of 23.11. The company’s 50 day moving average is GBX 2,566.10 and its 200-day moving average is GBX 2,903.88. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 103.77. Experian plc has a 1-year low of GBX 2,242 ($27.51) and a 1-year high of GBX 3,689 ($45.26).

The company also recently announced a dividend, which will be paid on Friday, July 22nd. Shareholders of record on Thursday, June 23rd will be given a dividend of $0.36 per share. This represents a yield of 1.07%. The ex-dividend date of this dividend is Thursday, June 23rd. This is an increase from Experian’s previous dividend of $0.16. Experian’s dividend payout ratio is currently 0.47%.

Several equities analysts have commented on EXPN shares. Shore Capital reiterated a “buy” rating on shares of Experian in a research report on Monday, May 16th. Citigroup lowered shares of Experian to a “neutral” rating and set a GBX 3,146 ($38.60) price objective for the company. in a report on Wednesday, March 30th. Morgan Stanley reiterated an “equal weight” rating on shares of Experian in a report on Wednesday, May 11th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Experian in a report on Friday, May 27th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a GBX 3,300 ($40.49) price objective on shares of Experian in a report on Thursday, May 19th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 3,316 ($40.68).

(Ad)

Whether you’re looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today’s futures markets!

Experian Company Profile (Get Rating)

Experian plc, together with its subsidiaries, operates as a technology company. The company operates through two segments, Business-to-Business and Consumer Services. It provides data services to identify and understand their customers, as well as to manage the risks related with lending. The company also offers analytical and decision tools that enhance businesses to manage their customers, minimize the risk of fraud, comply with legal requirements, and automate decisions and processes.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Experian right now?

Before you consider Experian, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Experian wasn’t on the list.

While Experian currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Source link

TagsExperianinsider buying and sellinginstant alertsLON:EXPN
Previous Article

The Mushy Middle – The Reformed Broker

Next Article

What Is Impact Investing? – Worth

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Stock Shares

    iHeartMedia (NASDAQ:IHRT) Shares Down 5.4% After Analyst Downgrade

    November 8, 2022
    By Megan
  • Investment

    Saratoga Investment Corp. (NYSE:SAR) Short Interest Up 35.7% in June

    July 3, 2022
    By Megan
  • Gold and Precious Metals

    Dundee Precious Metals (TSE:DPM) PT Raised to C$13.00

    September 27, 2022
    By Megan
  • Stock Shares

    Rathbones Group Plc Decreases Stock Position in Lockheed Martin Co. (NYSE:LMT)

    January 18, 2023
    By Megan
  • Investment

    AG Mortgage Investment Trust (MITT) Set to Announce Quarterly Earnings on Friday

    October 29, 2022
    By Megan
  • Stock Shares

    Toby Courtauld Buys 25 Shares of Great Portland Estates Plc (LON:GPE) Stock

    July 30, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Investment

    Pennsylvania Continues to Lead Nation, Investing $8.2 Million to Protect 32 Farms in 18 Counties from Future Development

  • Investment

    Charlotte’s Web Announces US$56.8 Million Investment from BAT

  • Financial Market

    Wall Street’s sleuth of bears is growing

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • January 29, 2023

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

  • January 29, 2023

    Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

  • January 29, 2023

    China to boost economic rebound, stabilize foreign trade, investment

  • January 29, 2023

    Senior Australian ministers to visit France, Britain to boost ties

  • January 29, 2023

    Does That Call For Deeper Study Of Its Financial Prospects?

Best Reviews

Latest News

Stock Shares

Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

Raymond James & Associates disclosed in its most recent 13F filing with the Securities and Exchange Commission that it increased its holdings in N.G.M. Biopharmaceuticals, Inc. (NASDAQ: N.G.M.) during the ...
  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    By Megan
    January 29, 2023
  • China to boost economic rebound, stabilize foreign trade, investment

    By Megan
    January 29, 2023
  • Senior Australian ministers to visit France, Britain to boost ties

    By Megan
    January 29, 2023
  • Does That Call For Deeper Study Of Its Financial Prospects?

    By Megan
    January 29, 2023
  • Recent

  • Popular

  • Comments

  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    By Megan
    January 29, 2023
  • China to boost economic rebound, stabilize foreign trade, investment

    By Megan
    January 29, 2023
  • Senior Australian ministers to visit France, Britain to boost ties

    By Megan
    January 29, 2023
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Australia’s economy: boom or bust?

    By Megan
    September 9, 2019
  • Australian economy suffers virus symptoms

    By Megan
    February 10, 2020
  • Australian economy likely already slowing in Q2 before Delta downturn

    By Megan
    August 30, 2021

Trending News

  • Stock Shares

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    Raymond James & Associates disclosed in its most recent 13F filing with the Securities and Exchange Commission that it increased its holdings in N.G.M. Biopharmaceuticals, Inc. (NASDAQ: N.G.M.) during the ...
  • Gold and Precious Metals

    Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    According to the most recent filing that Raymond James & Associates made with the Securities and Exchange Commission, the investment firm increased its holdings in Sandstorm Gold Ltd. (NYSE: SAND) ...
  • Investment

    China to boost economic rebound, stabilize foreign trade, investment

    China will consolidate and expand the momentum of its economic rebound, accelerate consumption recovery and stabilize foreign trade and investment, according to the decisions made at the State Council executive ...
  • Australian Economy

    Senior Australian ministers to visit France, Britain to boost ties

    SYDNEY, Jan 29 (Reuters) – Australia’s defence and foreign ministers on Sunday said they aimed to deepen security ties with France and Britain during visits to Europe this week, flagging ...
  • Investment

    Does That Call For Deeper Study Of Its Financial Prospects?

    Most readers would already be aware that Parkway Life Real Estate Investment Trust’s (SGX:C2PU) stock increased significantly by 7.0% over the past month. Given that stock prices are usually aligned ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.